TRCT
CAH icon

Tower Research Capital (TRC)’s Cardinal Health CAH Stock Holding History

Tower Research Capital (TRC)’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Sell
6,977
-1,601
-19% -$345K 0.04% 425
2025
Q4 		$1.76M Buy
8,578
+5,994
+232% +$1.13M 0.04% 369
2025
Q3 		$406K Sell
2,584
-4,981
-66% -$769K 0.01% 1002
2025
Q2 		$1.27M Sell
7,565
-7,126
-49% -$1.06M 0.03% 453
2025
Q1 		$2.02M Buy
14,691
+1,349
+10% +$172K 0.06% 280
2024
Q4 		$1.58M Buy
13,342
+3,869
+41% +$452K 0.03% 432
2024
Q3 		$1.05M Sell
9,473
-45,586
-83% -$4.77M 0.03% 515
2024
Q2 		$5.41M Buy
55,059
+50,087
+1,007% +$5.1M 0.09% 174
2024
Q1 		$556K Sell
4,972
-33,579
-87% -$3.62M 0.01% 806
2023
Q4 		$3.89M Buy
38,551
+28,072
+268% +$2.79M 0.05% 324
2023
Q3 		$910K Buy
10,479
+3,848
+58% +$348K 0.03% 575
2023
Q2 		$627K Buy
6,631
+2,162
+48% +$183K 0.02% 827
2023
Q1 		$338K Sell
4,469
-17,469
-80% -$1.32M 0.01% 1070
2022
Q4 		$1.69M Buy
21,938
+1,449
+7% +$110K 0.07% 206
2022
Q3 		$1.37M Sell
20,489
-15,274
-43% -$968K 0.02% 566
2022
Q2 		$1.87M Sell
35,763
-10,118
-22% -$575K 0.04% 398
2022
Q1 		$2.6M Buy
45,881
+27,748
+153% +$1.49M 0.02% 507
2021
Q4 		$933K Sell
18,133
-32,453
-64% -$1.59M 0.02% 733
2021
Q3 		$2.5M Buy
50,586
+45,021
+809% +$2.44M 0.06% 208
2021
Q2 		$317K Sell
5,565
-32,522
-85% -$1.9M 0.01% 1556
2021
Q1 		$2.31M Buy
38,087
+30,190
+382% +$1.67M 0.04% 425
2020
Q4 		$423K Buy
7,897
+2,087
+36% +$108K 0.01% 1119
2020
Q3 		$273K Sell
5,810
-6,881
-54% -$353K ﹤0.01% 2264
2020
Q2 		$662K Buy
12,691
+9,941
+361% +$512K 0.03% 794
2020
Q1 		$132K Buy
2,750
+1,496
+119% +$77.7K 0.01% 894
2019
Q4 		$63K Sell
1,254
-4,125
-77% -$213K 0.01% 1192
2019
Q3 		$254K Buy
+5,379
New +$246K 0.02% 884
2019
Q2 		– Sell
-8,120
Closed -$391K – 3704
2019
Q1 		$391K Sell
8,120
-4,205
-34% -$211K 0.02% 755
2018
Q4 		$549K Buy
12,325
+11,892
+2,746% +$620K 0.04% 395
2018
Q3 		$24K Sell
433
-20,611
-98% -$1.05M ﹤0.01% 2212
2018
Q2 		$1.03M Buy
21,044
+14,701
+232% +$834K 0.06% 346
2018
Q1 		$398K Buy
6,343
+3,866
+156% +$265K 0.03% 571
2017
Q4 		$152K Buy
2,477
+1,388
+127% +$85.8K 0.02% 671
2017
Q3 		$73K Buy
1,089
+492
+82% +$34.8K 0.01% 1640
2017
Q2 		$47K Buy
597
+430
+257% +$32.5K 0.01% 777
2017
Q1 		$14K Sell
167
-6,125
-97% -$482K ﹤0.01% 1529
2016
Q4 		$453K Buy
6,292
+6,008
+2,115% +$434K 0.05% 376
2016
Q3 		$22K Sell
284
-5,749
-95% -$465K ﹤0.01% 1546
2016
Q2 		$471K Buy
+6,033
New +$481K 0.05% 289
2015
Q3 		– Sell
-1,036
Closed -$87K – 4039
2015
Q2 		$87K Buy
1,036
+359
+53% +$31.7K 0.01% 952
2015
Q1 		$61K Buy
677
+596
+736% +$51.3K 0.01% 1304
2014
Q4 		$7K Sell
81
-6,550
-99% -$517K ﹤0.01% 2418
2014
Q3 		$497K Buy
+6,631
New +$482K 0.06% 261
2014
Q2 		– Sell
-6,202
Closed -$434K – 4049
2014
Q1 		$434K Buy
+6,202
New +$431K 0.06% 232
2013
Q4 		– Sell
-898
Closed -$47K – 4482
2013
Q3 		$47K Buy
898
+195
+28% +$9.91K 0.01% 1958
2013
Q2 		$33K Buy
+703
New +$32.1K ﹤0.01% 1257

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tower Research Capital (TRC)'s CAH Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Cardinal Health (CAH) stake by 19% in Q1 2026, selling an estimated $345K and leaving 6,977 shares worth $1.47M. The position accounts for 0.04% of the portfolio, ranked #425.

Tower Research Capital (TRC) first reported a position in CAH in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.41M in Q2 2024. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Tower Research Capital (TRC) held 6,977 shares of Cardinal Health worth $1.47M as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,601 Cardinal Health shares in Q1 2026, an estimated $345K.
  • Cardinal Health made up 0.04% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #425 holding.
  • Tower Research Capital (TRC) first reported a position in Cardinal Health in Q2 2013 and has held it in 46 quarters since.
  • Tower Research Capital (TRC)'s Cardinal Health position peaked at $5.41M in Q2 2024.
  • 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.